AvalehtLLY • SWX
add
Eli Lilly And Co
Viimane sulgemishind
750,00 CHF
Aasta vahemik
500,00 CHF - 830,00 CHF
Turuväärtus
872,46 mld USD
Keskmine maht
1,00
P/E suhe
-
Dividendimäär
-
Põhibörs
NYSE
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Käive | 11,30 mld | 35,98% |
Põhitegevusega seonduv kulu | 4,71 mld | 13,15% |
Puhastulu | 2,97 mld | 68,27% |
Puhaskasumimarginaal | 26,25 | 23,76% |
Puhaskasum aktsia kohta | 3,92 | 85,78% |
EBITDA | 4,83 mld | 78,69% |
Tõhus maksumäär | 15,64% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 3,37 mld | 14,45% |
Kogu vara | 71,87 mld | 31,12% |
Kõik kohustused | 58,24 mld | 33,38% |
Kogu omakapital | 13,64 mld | — |
Emiteeritud aktsiate arv | 900,43 mln | — |
Hinna ja väärtuse suhe P/B | 49,80 | — |
Varade tasuvus | 16,27% | — |
Kapitali tasuvus | 26,97% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | juuni 2024info | Y/Y muutus |
---|---|---|
Puhastulu | 2,97 mld | 68,27% |
Põhitegevuse rahakäive | 1,47 mld | 132,03% |
Investeeringute raha | −2,20 mld | −378,92% |
Finantseerimise raha | 1,56 mld | 250,52% |
Raha ja raha ekvivalentide muutus | 763,40 mln | 189,66% |
Tasuta rahavoog | 2,37 mld | 27,27% |
Teave
Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.
As of 2024, the company is ranked 127th on the Fortune 500 with revenue of $34.12 billion. It is ranked 221st on the Forbes Global 2000 list of the world's largest publicly-traded companies and 252nd on Forbes' list of "America's Best Employers". It is recognized as the top entry-level employer in Indianapolis.
Lilly is known for its clinical depression drugs Prozac, Cymbalta, and its antipsychotic medication Zyprexa. The company's primary revenue drivers are the diabetes drugs Humalog and Trulicity.
Lilly was the first company to mass-produce both the polio vaccine, developed in 1955 by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA, including Humulin, Humalog, and the first approved biosimilar insulin product in the U.S., Basaglar. Wikipedia
Tegevjuht
Asutatud
1876
Veebisait
Töötajate arv
43 000